Enprostil
Izgled
(IUPAC) ime | |||
---|---|---|---|
Metil 7-[(1S,2S,3S)- 3-hidroksi-2-[(S,E)-3-hidroksi-4-fenoksibut-1-enil]-5-oksociklopentil]hepta-4,5-dienoat | |||
Klinički podaci | |||
AHFS/Drugs.com | Internacionalno ime leka | ||
Identifikatori | |||
CAS broj | 73121-56-9 | ||
ATC kod | A02BB02 | ||
PubChem[1][2] | 51744 | ||
UNII | J4IP5Z9DAU | ||
KEGG[3] | D01891 | ||
Hemijski podaci | |||
Formula | C23H28O6 | ||
Mol. masa | 400,46 g/mol | ||
SMILES | eMolekuli & PubHem | ||
| |||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status |
Enprostil je sintetički prostaglandin koji je sličan sa dinoprostonom. Enprostil je veoma potentan inhibitor sekrecije želudačne HCl.[4]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
- ↑ Roszkowski, AP; Garay, GL; Baker, S; Schuler, M; Carter, H (1986). „Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester”. The Journal of Pharmacology and Experimental Therapeutics 239 (2): 382–9. PMID 3095537.
- Toshina, K.; Hirata, I.; Maemura, K.; Sasaki, S.; Murano, M.; Nitta, M.; Yamauchi, H.; Nishikawa, T. i dr.. (2000). „Enprostil, a Prostaglandin-E2 Analogue, Inhibits Interleukin-8 Production of Human Colonic Epithelial Cell Lines”. Scandinavian Journal of Immunology 52 (6): 570–5. DOI:10.1046/j.1365-3083.2000.00815.x. PMID 11119262.
- Tari, Akira; Hamada, Masanori; Kamiyasu, Toshiki; Sumii, Koji; Haruma, Ken; Inoue, Masaki; Kishimoto, Shinya; Kajiyama, Goro i dr.. (1997). „Effect of enprostil on omeprazole-induced hypergastrinemia and inhibition of gastric acid secretion in peptic ulcer patients”. Digestive Diseases and Sciences 42 (8): 1741–6. DOI:10.1023/A:1018825902055. PMID 9286243.
- Ching, C. K.; Lam, S. K. (1995). „A comparison of two prostaglandin analogues (enprostil vs misoprostol) in the treatment of acute duodenal ulcer disease”. Journal of Gastroenterology 30 (5): 607–14. DOI:10.1007/BF02367786. PMID 8574332.